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INTRODUCTION 
As you may imagine, I feel quite privileged to deliver the first presidential ad- 
dress to this Society. Although somewhat overlooked, in recent years the evolution of 
the field of genetic epidemiology has been just as dramatic as the evolution of other 
fields of genetic research, and the formation of this Society is a timely development. 
In 1954, W.J. Schull and I published a little textbook entitled Human Heredity. We 
took turns writing chapters for it. He, for instance, wrote those very nice chapters 
on statistical genetics. We felt there should be in the book a chapter on “Genetics 
and Epidemiology”-the first such chapter that I am aware of-and to me fell the 
challenge of writing that chapter. Anyone with any doubts as to how greatly the sub- 
ject of genetic epidemiology has advanced in recent decades needs only go back and 
consider the comparative simplicity of what I wrote some 40 years ago. 
Currently, genetic epidemiology presents two rather different faces. Face one is 
concerned with teasing the genetic component out of complex sets of family data. 
Here the objectives may vary from an attempt to link a marker gene to a phenotype, 
to an attempt to identify the existence of genetically caused variation in a phenotype 
by means of complex segregation analysis. Face two, on the other hand, is Concerned 
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with the attempt to demonstrate that some rather unique experience of a population 
is reflected in one or more genetic endpoints. 
No matter which of these approaches the genetic epidemiologist pursues, he is 
bedeviled by the problem of “false positives.” There is no mystery as to how most of 
these false positives occur. It is not uncommon in much of what I will term “shot- 
gun” genetic epidemiology for the investigator to explore the impact of as many as 
20 different parental variables on perhaps 5 endpoints in their children. This matrix 
of 100 outcomes should, even in the absence of any real associations in the data, 
yield, on average, four outcomes significant at the 5% level of probability and one 
at the 1% level. These “false positives,” if the endpoint in question is one of so- 
cietal significance-and these studies are presumably not undertaken for frivolous 
reasons-are often an apparent new cause for alarm. On the other hand, these “shot- 
gun” studies, widely targeted though they may be, almost invariably have a rationale 
which leads to some expectation of one or more positive findings. Thus the practical 
issue is to determine which among the positive findings in a large-scale epidemiolog- 
ical study are meaningful and need to be pursued further and how best to proceed. 
In this connection, the term “false positive” is something of a misnomer. The data 
are not “false,” but the conventions of statistical inference lead to some apparent out- 
comes which will not be supported by repeat studies. 
In this presentation I shall describe what I consider to be the most major false 
alarm in type 2 genetic epidemiology in recent years, one that has consumed a great 
deal of public money and scientific time. My purpose is constructive: I hope by virtue 
of a thorough public airing of this situation, to help move the field of genetic epi- 
demiology to a level of sophistication which will render the reoccurrence of such 
events improbable. Note that I do not aspire to render such events impossible, just 
less probable. The mind-set of the American people, and to a lesser extent, of other 
Western World peoples, is now so litigious that change will come slowly. The fol- 
lowing quotation puts it quite succinctly. 
Serious efforts to impose legal controls on the sources of societal risk date 
only from the mid-1960s. Most prominent in the public mind has been 
the creation of specialized federal agencies to directly regulate particular 
societal dangers-the Environmental Protection Agency, the Occupational 
Health and Safety Administration, the National Highway Traffic Safety 
Administration, and the Consumer Product Safety Commission as exam- 
ples. But far more pervasive in scope and far more effective in impact than 
agency regulation has been the expansion of civil law to control risk. Since 
the late 1960s, our civil justice system has adopted the premise that civil 
damage awards enforcing liability rules and statutory rights can optimally 
regulate every source of societal risk. Building from this premise, our civil 
courts have become the most powerful institution of the modem state for 
regulating risk [Priest, 1990, p 2071. 
CHILDHOOD LEUKEMIA IN WEST CUMBRIA 
The point of departure for this presentation is the epidemiological study con- 
ducted by Martin Gardner and associates on the occurrence of leukemia and lym- 
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phoma among young people in West Cumbria, England [Gardner et al., 1987a,b, 
1990a,b]. In 1983, Yorkshire television drew attention to an apparent excess of child- 
hood leukemia in the vicinity of the Sellafield Nuclear Reprocessing Plant, which 
is located in West Cumbria, England. The presentation was sufficiently compelling 
that the English government commissioned a survey by an Independent Advisory 
Group, which confirmed that there was indeed an excess [Black, 1984; Gardner et 
al., 1987a,b], and Gardner and associates were then requested to undertake a study 
of associated risk factors, with particular reference to factors related to the plant. The 
subjects were 52 persons with leukemia, 22 with non-Hodgkin’s lymphoma, and 23 
with Hodgkin’s disease, all with onset in people born in the area between 1950 and 
1983, with diagnosis under the age of 25, and 1,001 controls matched for sex and 
age taken from the same birth registers as the cases [Gardner et al., 1990a,b]. Asso- 
ciations were sought with such factors as place of residence, viral infections, child’s 
play habits, and parental occupational histories. As best I can estimate, some 80 pos- 
sible associations were investigated. (This number in itself immediately raises the 
possibility of several “statistically significant” false positive associations simply on 
the basis of the number of tests performed.) 
The principal positive finding was that relative risks for leukemia and non- 
Hodgkin’s lymphoma were higher in children born near Sellafield and in children 
of fathers employed at the plant. For example, the relative risk was 2.4 [95% confi- 
dence interval (CI) of 1.0-5.71 for children of fathers employed at Sellafield at the 
time of their conception and 6.4 (CI 1.67-26.3) for children of fathers receiving a to- 
tal preconceptual (external-badge-recorded) dose of ionizing radiation of more than 
100 mSv equivalents (but there were no exposures exceeding approximately 200 mSv 
equivalents). The authors focused special attention on the village of Seascale, 3 km 
south of Sellafield, where a clustering of cases had been observed. Altogether 7 
cases had been diagnosed in residents of the village under 25 years of age in the 
29 years from 1955 to 1983, 5 of which were in children under 10 years of age, 
when less than 1 case at these ages (actually, 0.5 cases) would have been expected at 
national rates. Four of the fathers of the affected children were employed in the Sel- 
lafield plant (expectation 0.6; relative risk 6.4), where they had received estimated 
total preconceptual (badge) doses of ionizing radiation ranging from 97 to 188 mSv 
equivalents over a period of 6-13 years. (For those more accustomed to the old units, 
200 mSv equivalents is 20 rem.) These doses were well within internationally ac- 
cepted occupational guidelines. The authors concluded that “this result suggests an 
effect of ionizing radiation on fathers that may be leukemogenic in their offspring, 
though other, less likely, explanations are possible.” That they believe this effect is 
genetic is indicated by their comparison of their findings with other, avowedly ge- 
netic studies, some to be mentioned later. The sensitivity of the human genome to 
the genetic effects of ionizing radiation implied by this interpretation is far, far in 
excess of current estimates, a statement I will document in detail in due course. 
Understandably, the publication of these findings in the British Medical Journal 
in February of 1990 elicited a flurry of comments, some incredulous, some hailing 
a new major insight into radiation effects. The study of my associates and self on 
malignancies, including leukemia and lymphoma, in the F1 of parents exposed to the 
explosions of the atomic bombs were then in press, not to appear until June 1990 
[Yoshimoto et al., 19901, so when contacted by Science for comment, I could only 
216 Nee1 
express general disbelief and promise a more definitive response later. Needless to 
say, the world did not wait for our statement. A British law firm, Leigh, Day, and 
Company, advertised its willingness to file claims against the organization operating 
the facility, British Nuclear Fuel Plc (BNFL), and relatives of two of the children soon 
initiated action against BNFL, claiming damage for personal injuries and, in one of 
the two cases, death. A finding for the plaintiffs would challenge, worldwide, present 
permissible occupational exposures to ionizing radiation, as well as the validity of a 
major corpus of experimental data from the mouse, and the observational data from 
Japan on the children of atomic bomb survivors. Such a finding would also trigger 
a flood of similar legal actions. The stakes were high. So was the cost: The London 
Times has estimated (1 5 October 1992) that the resulting procedures, before the Royal 
High Courts of Justice of England, are expected “to be a record breaking legal action, 
costing up to &lo million” (US dollars = 16 million). (The expenses of both plaintiffs 
and defendant will ultimately be met by the government.) 
Concerning the reliability of the findings of Gardner and associates, there can be 
little doubt. A parallel study by McKinney and associates [1991] on parental occupa- 
tions of children with leukemia in West Cumbria, North Humberside, and Gateshead, 
all areas in which high rates of childhood leukemia had previously been documented, 
confirmed the finding of the Gardner group in West Cumbria, not surprising in view 
of the overlap in subjects. McKinney et al. [1991] also reported significant associ- 
ations of childhood leukemia with the preconceptional exposure of fathers to wood 
dust and benzene. The significance of these latter two findings must be viewed in light 
of the fact that by the authors’ estimate, 480 comparisons were made. It is notewor- 
thy that this study failed to confirm previously reported associations of childhood 
leukemia with parental exposure to pesticides, plastics, and paint and pigments-but 
these facts did not find their way into the abstract, let alone inspire a press release! 
Draper et al. [1993] several years later also confirmed the excess of leukemia in the 
Seascale area, and added additional data for 1984-1990, finding for the latter pe- 
riod that “the incidence of malignant disease, particularly lymphoid leukemia and 
non-Hodgkin’s lymphomas in young people aged 0-24, in Seascale was higher than 
would be expected.” 
LEGAL ACTION UNFOLDS 
The trial which resulted was conducted by a single judge in the Royal High 
Courts of Justice in London. I became involved in the trial, as a witness for the 
defense, in May of 1990. Ordinarily, I eschew legal involvements as carefully as I 
avoid contact with poison ivy, to which I am quite sensitive, but too much was at 
issue. I would like to share some of the developments of the past 3 years with you, 
because they provide an absolute textbook example of the complexities in mankind’s 
efforts to define environmental/occupational risks. Everything I will discuss is either 
in the transcripts of the trial or has now appeared in the open scientific literature. 
The trial was conducted according to long-established procedures for civil ac- 
tions in England. The parties to the action agree on a sequence in which evidence 
will be introduced, in this instance, primarily the dosimetry, pathology, epidemiology, 
and genetics of the situation. Each side assembles an appropriate battery of consul- 
tants, who prepare Expert Reports. The Reports are exchanged by the two sides, and, 
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based on the statements of the other side, a consultant may find himself preparing, 
as I did, a second, third, and even fourth Report. Comes the day when the consultant 
appears in court. First he is led through the substance of his reports by the counsel 
for the side he represents, then cross-examined, and then finishes in the hands of his 
counsel. It was all very orderly, but the fact that to make their case, counsel for the 
plaintiffs, guided in no small measure by the statements of their consultants, had to 
discredit the studies in Japan on the children of atomic bomb survivors with which I 
have been associated for some 47 years, did bring a bit of tension into the proceed- 
ings. In fact, I’m afraid I was unprepared for the level of innuendo, obfuscation, and 
distortion to which the plaintiffs’ counsel resorted in attempting to cast doubt upon 
the validity of both the Japanese and murine data. Such tactics are a sad commen- 
tary on the adversarial ambience which characterizes society’s efforts to deal with 
the type of complex scientific data with which it is increasingly confronted in en- 
vironmental issues. With the legal profession willing to engage in such strategy to 
make a case, I am resigned to the fact that a balanced view of radiation (and other 
environmental) risks is not imminent. 
Both the presiding judge and the barristers representing the two sides were gen- 
eralists. By the time the case came to trial, the Expert Reports had grown to a 
formidable library, as did the testimony, which extended intermittently over a pe- 
riod of some 8 months. I was greatly impressed by the rapidity with which judge 
and barristers appeared to master the content and jargon of epidemiology and genet- 
ics, but at the same time concerned by the tremendous demands a highly technical 
hearing such as this places on a single judge, no matter how competent he is. Unfor- 
tunately, the plaintiffs’ suit had the kind of surface plausibility that sometimes wins 
cases in a court of law. I would like now to run through the evidence that suggested 
to me (and other expert witnesses for the defendant) that the conclusions of Gardner 
and associates concerning the role of paternal exposure to ionizing radiation in the 
etiology of childhood leukemia in this setting were erroneous. Some of this evidence 
may be familiar to you, but I believe it will be useful to lay it all out in one place. An 
unusual feature of this trial was that relevant evidence continued to become available 
throughout the trial; I will introduce this “new” evidence last. 
1 .  A comparison with the data on leukemia in the children of survivors of the atomic 
bombs. The genetic data of greatest relevance to the interpretation of the findings 
of the Gardner-group studies are those collected in the aftermath of the Hiroshima- 
Nagasaki bombings [reviewed in Nee1 and Schull, 19911. Of special relevance are the 
studies on the occurrence of malignancies, including the leukemias, in the children of 
survivors and suitable control children [Yoshimoto et al., 1990, 19911. In the course 
of these latter studies, an attempt was made to identify, on the basis of death certifi- 
cates and the tumor registries maintained in Hiroshima and Nagasaki, all malignant 
tumors occurring during the period 1946-1 985 in the cohort of children born in these 
two cities to parents who were within 2,000 m of the hypocenter at the time of the 
bombings and a suitably matched cohort of children whose parents were unexposed. 
The distribution of radiation doses in the combined cohorts, totaling 72,216 persons, 
is shown in Table I. The average conjoint gonadal acute dose of ionizing radiation for 
the exposed parents was 0.44 Sv equivalent. (Dose must be expressed in Sv equiv- 
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the atomic bombs.) The relationship between dose and incidence of malignancy was 
tested by a linear multiple regression model which included city, sex, and year of 
birth. There were 92 reports of malignant neoplasms in the combined cohorts. For 
analytic purposes, they were subdivided into three classes: leukemia, neoplasms in 
which genetic factors have been implicated (designated “heritable”), and other (Table 
11). For present purposes, we need only note the complete absence of any suggestion 
of an effect of parental exposure to ionizing radiation on the occurrence of leukemia. 
In view of the lack of any suggestion of a radiation effect, we saw at the time no 
reason to carry the analysis further. (Philosophical point: I firmly believe that if main 
effects are negative, slicing and dicing the data with further analyses in the hopes of 
turning something up, if carried far enough, always yields a “statistically positive” 
finding which immediately becomes a source of embarrassment.) When, however, the 
data from Japan assumed such a prominent role in the trial, M.P. Little of the U.K. 
National Radiological Protection Board undertook major further analyses of our data 
[Little, 1990, 1991a,b, 1992, 19931. It is the policy of the agency conducting follow- 
up studies in Japan on the late effects of the atomic bombs, the Radiation Effects 
Research Foundation, to make its data tapes available to qualified investigators. Ob- 
taining his copy of our data tapes on malignancy in the F1, Little first confirmed the 
validity of our analysis but then proceeded to pursue a number of additional points, 
as follows: 
a. Little [ 19901 estimates not only that the two studies are statistically incompat- 
ible but that taken at face value the sensitivities with respect to leukemia implied by 
the Gardner study are 50-80 times greater than the results of the study in Japan. 
The implied difference between the two studies is even greater because whereas 
the Japanese doses were calculated gonadal exposures, the exposures in Sellafield 
were measured from film badges worn on the trunk (which overestimate gonadal 
exposures). 
b. We had analyzed our findings with respect to conjoint parental exposures 
and in the absence of any suggestion of an effect, had not considered the parents 
separately. With the emphasis on paternal exposure in the Gardner-group study, 
TABLE 11. Regression Coefficients (Standard Errors in Parentheses) From a Linear Multiple 
Regression Analysis (Method of Least Squares) of the Incidence of Cancer Below the Age of 
20 Years, by Conjoint Parental Dose (Sv Equivalents, RBE = 20), City, Sex, and Birth Years, 
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+n = 72,216 subjects. 
aAdjusted for average number of years between bombings and births. 
*0.01 < P < 0.05. 
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Little [1990] examined effects of parental exposures separately, finding no hint of a 
difference. 
c. Because of the possibility that during the difficult, immediate post-war period 
in Japan, childhood leukemia was underdiagnosed, and so an “early” increase in the 
frequency of this disease in the children of the exposed was missed, Little [1992] 
reanalyzed our data for a time trend. None was observed; the constancy of diagnoses 
(especially in the children of the unexposed) suggests that underdiagnosis in the early 
years of the study did not significantly influence the study. Furthermore, had there 
been an excess of childhood leukemia in the children of the exposed, on the scale 
suggested by the Gardner study (see below) and had the diagnoses been missed, 
their deaths would have inflated some one or more of the 10 disease categories under 
which deaths were analyzed. There is no evidence for such an inflation of mortality 
in a particular disease category, neither in our analysis [Yoshimoto et al., 19911 nor 
in the reanalysis of Little [1991a, 19921. 
The treatment of this latter point by the plaintiffs provides an example of the ob- 
fuscation to which I referred earlier. This consisted especially in raising doubts about 
the validity of the study, doubts whose quantitative implications had not been thought 
through. The barristers for the plaintiffs, noting the approximately 7-fold greater 
sensitivity of mature and maturing sperm to the genetic effects of ionizing radiation 
[Russell, 19631, and noting that those fathers of the leukemic children who worked 
in Sellafield would be subjecting maturing sperm to radiation, strongly urged that 
the “Sellafield effect” especially reflected the radiation of mature sperm, and that 
the corresponding effect in Japan would result in a high frequency of leukemia in 
the children conceived just after the bombings and born during 1946, a frequency 
missed in our study because of poor diagnostic standards during the early years of 
our study. Aside from the conflict with the actual data, mentioned above, this sug- 
gestion requires an outlandish radiosensitivity of maturing and mature sperm. Since, 
as mentioned earlier, the “exposed” fathers in the study cohort had been employed 
at Sellafield for 6 1 3  years, only a fraction of the (maximum) dose of 200 mSv- 
certainly less than 5%-would have reached maturing and mature sperm. In the 
Japanese study, during May to November of 1946 (when all the children resulting 
from zygotes fertilized by sperm which were mature and maturing at the time of the 
bombing would have been born), 263 children were born to parents whose combined 
exposures were 20.01 Sv equivalent and 1,189 to parents receiving <0.01 Sv equiv- 
alent. In the former group, the mean paternal gonad dose was 0.26 Sv equivalent and 
the mean maternal dose was 0.12 Sv equivalent. No cases of leukemia were detected 
in this group, but one case is on record among the children whose parent received 
<0.01 Sv equivalent. If the (very approximately) 10 mSv of radiation to mature and 
maturing sperm received by the Sellafield workers (a maximal dose estimate) was pri- 
marily responsible for the 6.4-fold increase in the frequency of childhood leukemia 
in Seascale, then the expectation in Japan would be (again, very approximately) for 
260/10 X 6.4 X 263 X 0.05%, or 21.9 children with the disease on the basis of pater- 
nal radiation alone. (This calculation assumes childhood leukemia is due to a single 
dominant, completely penetrant gene and ignores a dose rate effect (see below), the 
assumptions most favorable to the plaintiffs’ case.) While I attach little confidence 
to these precise numbers, it is clear the extrapolation of the Seascale findings to the 
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Japanese situation requires a frequency of childhood leukemia in that early period 
which would not have gone undetected! Furthermore, the greater sensitivity of ma- 
ture and maturing sperm (compared with spermatogonia) implied in their argument 
exceeds the Russell factor of 7 by a factor of at least 300 (although again a precise 
calculation is difficult). 
The data on the genetic effects of the atomic bombs accumulated over the past 
45 years in Japan of course extend far beyond the matter of childhood malignan- 
cies. The epidemiologic approach employed in Hiroshima and Nagasaki has been a 
cohort study, based on all the children born in these two cities between 1946 and 
1985 to survivors who received significant amounts of radiation. The cohort consists 
of 3 1,150 children; there is a somewhat larger, age- and sex-matched cohort of chil- 
dren born in these two cities to parents who did not receive increased radiation from 
the bombings. Over the years, in a major collaborative effort between Japanese and 
American investigators, under the auspices of the Atomic Bomb Casualty Commis- 
sion and its successor agency, the Radiation Effects Research Foundation, a wide 
variety of studies have been performed on these cohorts, or suitable subsets thereof. 
These studies include the following: frequency of stillbirth, frequency of congen- 
ital malformation, sex ratio, death among liveborn children up to an average age 
expectancy of 26 years, physical development at various ages, presence of selected 
chromosomal abnormalities (sex-chromosome aneuploidy, reciprocal translocations), 
occurrence of mutations affecting the electrophoretic mobility or physiological activ- 
ity of a series of 30 polypeptides, and, of course, the cancer studies. 
In recent years, these analyses have been presented on a variety of occasions, 
and I feel I can be quite brief in summarizing the findings [cf. Neel and Schull, 
19911. The basic analysis of these data employed, where feasible, a linear multiple 
regression model of occurrence of indicator on conjoint parental gonadal radiation 
dose, using the revised dose schedule which became available in 1986 (DS86). In 
no case was a regression statistically significant. Because the observations were all 
on the same cohorts, we felt it appropriate to combine these regressions, to obtain a 
single summary figure for the effect of the exposures. (For technical reasons, the re- 
gressions for sex-ratio, reciprocal translocations, and physical development were not 
incorporated into this summary analysis.) We also estimated the contribution, each 
generation, of parental mutation to the various indicators, and summed these contri- 
butions. The mutational doubling dose is defined as the amount of ionizing radiation 
that will produce, with reference to the indicators under study, the same frequency 
of mutations as would occur spontaneously each generation. In these data the esti- 
mated total contribution from spontaneous mutation in the preceding generation to 
the sum of the endpoints pursued is between 0.0063 and 0.0084. The combined re- 
gression term is +O.O0375/Sv equivalent. The doubling dose is derived by dividing 
the latter into the former, and is estimated at between 1.7 and 2.2 Sv equivalents. 
The range indicates uncertainty about the exact mutational contribution to some of 
the indicators and does not include a statistical error of estimation [for a discussion 
of the problem of assigning an error term, see Neel and Schull, 19911. I note that 
ordinarily one does not manipulate non-significant findings in this fashion, but re- 
mind you that we accept that the radiation exposure did result in some mutations in 
Hiroshima and Nagasaki. We are not testing the hypothesis of radiation-induced mu- 
tations in this study but rather accepting the data at face value in order to derive an 
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estimate. I should further emphasize that this estimate is an average for the sexes; 
in the absence of any statistically significant findings for the sexes combined it has 
not seemed meaningful to subdivide the data further and analyze for the effects of 
maternal and paternal exposure separately. 
Most human exposures to ionizing radiation will be relatively low level, chronic, 
or intermittent, rather than the relatively high-level exposures sustained by a sizable 
fraction of atomic bomb survivors. This was certainly the case at Sellafield. One of 
the most significant findings to emerge from the extensive studies of mouse radia- 
tion genetics, to be discussed shortly, was that the genetic yield of a given amount 
of ionizing radiation is higher if the radiation is delivered acutely rather than chron- 
ically. The exact differential depended on the endpoint under study, but for “point 
mutations,” as studied in the male-based, 7-specific-locus test of Russell [ 195 11, 
the conversion factor was about 3 at the gonadal doses of 3 and 6 Gy employed 
in the mouse experiments [Russell et al., 19581. Accepting the parameters devel- 
oped by Abrahamson and Wolff [1976] for the linear and quadratic components of 
the radiation effect for the Russell system, and considering the distribution of the 
estimated parental gonad exposures in the study in Japan, we have elected to em- 
ploy a lower dose rate factor, of 2, for the human material. The doubling dose for 
chronic ionizing radiation in humans is therefore estimated at between 3.4 and 4.5 Sv 
equivalents. 
2. A comparison with the murine data. During and following World War 11, a very 
major program in the radiation genetics of mice came into being, with the thought 
that the domestic mouse was the best human surrogate available in genetic risk set- 
ting. On the basis of segments of those data, but especially the results of the Russell 
7-locus test system, the genetic doubling dose of acute radiation for mice has been set 
at about 0.4 Gy [Liining and Searle, 19711 and this estimate was often extrapolated 
to humans [United Nations, 1977, 1982, 1986, 19881. Given the dose rate factor for 
mice mentioned earlier, this translated to a doubling dose for chronic ionizing radia- 
tion of about l .2 Gy. (Under these circumstances, the genetic effectiveness of l .O Gy 
should be the same as 1 .O Sv equivalent.) The discrepancy between this estimate and 
that which we were developing for humans was somewhat disturbing, to the extent 
that in 1989 I asked Dr. Susan Lewis to join me in a reanalysis of the murine data 
“eel and Lewis, 19901. As we got into our subject, we became aware of many rea- 
sons to be cautious in a direct comparison of the two species with respect to such 
endpoints as congenital malformations, stillbirths, or survival of liveborn offspring. 
The most appropriate comparison with the human estimate seemed to be that de- 
rived from all the different specific locus or phenotype test systems developed for 
the mouse, including some whose results had received relatively little attention be- 
cause the smallness of the radiation effect seems to have raised questions concerning 
the reliability of the system. Table I11 summarizes the results obtained with acute ion- 
izing radiation for all 8 of these systems. The simple unweighted average of these 
various estimates of a doubling dose is 1.35 Gy. The implication is that the genetic 
loci incorporated into the Russell 7-locus test are more mutable than the loci which 
are the basis for the other test systems; elsewhere we have presented reasons why 
this might be the case [Neel and Lewis, 19901. Employing a dose rate factor of 3 for 
the extrapolation from acute to chronic radiation under these circumstances, we ob- 
tained an estimate of the doubling dose of chronic radiation of 4.05 Gy, in surprising 
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TABLE 111. Summary of the Estimated Gametic Doubling Doses for the Acute, “High-Dose” 
Radiation of Spermatogonia Yielded by the Various Specific-Locus/Specific-Phenotype Systems 
Developed in the Laboratory Mouse* 
System Doubling dose (Gy) Strain of origin of treated males 
Russel 7-locus 0.44 101 X C3H 
Dominant visibles 0.16 Various 
Dominant cataract 1.157 101/E1 X C3H/E1 
Skeletal malformations 0.26 101 
Histocompatibility loci >2.60 C57B 1/6JN 
Recessive lethals DBA 
0.80 1.77 C3H/HeH X 101/H 
4.00 CBA, C3H 
0.1 1 Various 
C3H/HeH X 101/H 
OS1 1 
Loci encoding for proteins 
Recessive visibles 3.89 
Average 1.35 
*Details concerning the source of the data and the calculations can be found in Nee1 and Lewis [1990]. 
agreement with the estimate based on the studies in Japan. I hasten to add that there 
is no theoretical reason to expect such agreement, but it is somehow reassuring. 
One set of murine data deserves special mention in the context of the Gardner 
study, namely, Nomura’s data on cancer, including leukemia, in the offspring (fol- 
lowed up to 8 months) of male mice receiving rather large doses (up to 5.04 Gy) of 
acute ionizing radiation [Nomura, 1982, 1990, 19911. The plaintiffs placed great re- 
liance on these data. In considering their relevance, it must be recalled that in the 
early days of mouse genetics, many strains were specifically selected for high cancer 
frequencies, and it is often difficult to ensure that modern strains do not incorporate 
some of this ancestry. The spectrum of spontaneous malignancies in the mice em- 
ployed by Nomura differed markedly from the human spectrum. For instance, in the 
two strains employed the frequencies of leukemia were 1 .O% and 0.4%, respectively, 
contrasted with the worldwide frequency of childhood leukemia in humans (including 
our own study) of about 0.05%. Furthermore, the childhood tumors with the strongest 
genetic component in humans, retinoblastoma, Wilms’ tumor, and, possibly, neuro- 
blastoma, which would be landmark tumors in any study of the genetic effects of 
radiation on humans, were not recognized in the mouse. Be this as it may, following 
the exposure of male mice to an acute radiation dose of 5.04 Gy, the frequency of 
leukemia in the offspring increased to 4.75% and 3.91%, respectively, in the strains 
employed by Nomura. Thus, in the Nomura system, a dose of 0.2 Gy (which is a 
maximum estimate of the average amount of badge dose radiation received by the 
Sellafield fathers) should increase the leukemia frequency by only 15-35%, whereas 
in the work of Gardner and associates, this same dose to fathers resident in Seascale 
is reported to result in a 640% increase in leukemia and lymphoma. I make the Sel- 
lafield findings to indicate an 18- to 43-fold greater sensitivity of this endpoint than 
Nomura’s findings. Furthermore, a dose rate factor of 3 must be invoked to adjust for 
the chronic nature of the radiation experienced by Sellafield workers, and a further 
factor of approximately 2 must be invoked to adjust for the fact that the Sellafield 
exposures were measured at the surface of the trunk rather than calculated for the 
gonad. These two adjustments require a factor of 6, and the Gardner findings now 
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acquire a sensitivity 108-258 times greater than those of Nomura, if you accept the 
appropriateness of the comparison, which I do not. (This calculation of necessity ne- 
glects the possible role of internal emitters of ionizing radiation in the Sellafield data, 
but from the information available it seems very unlikely to add more than 20% to the 
collective equivalent dose to the testes associated with the Seascale births [Wakeford 
et al., 19941. 
3. Further on why the association reported by Gardner and associates cannot rep- 
resent cause and effect. We have just seen that at the phenomenological level, neither 
the data from Japan nor from mice support a genetic explanation of the association 
reported by Gardner and colleagues. Two additional arguments cast further doubt on 
a genetic explanation for the observed association. 
a. The genetics of human leukemia. Unlike such malignancies of childhood as 
retinoblastoma and Wilms’ tumor, for which there is clear evidence that an abnor- 
mal allele transmitted from a parent can play a major role in the causation of the 
tumor, such evidence has not been forthcoming for the childhood leukemias. These 
leukemias, collectively, are some 10 times more common than retinoblastoma, yet 
there have been reported only a relatively small number on non-syndromic family 
clusters [Blattner et al., 1976; Draper et al., 1977; Felix et al., 1992; Fraumeni et 
al., 1969; Gunz et al., 1978; Miller, 1971; Pendergrass et al., 1975; Snyder et al., 
1970; Steinberg, 1960; Zuelzer and Cox, 19691. In the past, the fatal nature of child- 
hood leukemia has not permitted an adequate test of a genetic hypothesis. Now, how- 
ever, with the improved treatment of childhood leukemia characterizing the last 30 
years, there are long-term survivors who, reaching adulthood, are reproducing. Draper 
[1989] in a review finds that of some 40 children born to such survivors, none has 
developed similar disease. Were 40 children born to survivors of retinoblastoma, the 
expectation (allowing for the fact that some retinoblastomas are due only to somatic 
mutations) would be that about 8 children would themselves develop retinoblastoma. 
Recently, Felix et al. [1992] have reported what is apparently the first example of 
parent-offspring transmission of childhood leukemia. Also, of 1 18 children of men 
and women who had survived a closely related malignancy, namely, early-onset non- 
Hodgkin’s lymphoma, none has developed leukemia nor non-Hodgkin’s lymphoma 
[Draper, 19891. 
On the basis of present evidence, not more that 5% of childhood leukemia can 
be attributed to a genetic basis such as accounts for familial retinoblastoma. This is 
the fraction which should be responsive to a radiation-induced mutation in the ap- 
propriate gene in a parent. I remind you that the Sellafield exposures were chronic, 
which by comparison with the Japanese experience should reduce any genetic yield 
by 1/2, and the fact that badge, not gonad, doses were employed should introduce 
another factor of - 1 /2. Earlier, I quoted Little’s estimate of a 50- to 80-fold discrep- 
ancy between the Gardner results and the Hiroshima-Nagasaki findings. That was at 
the phenomenological level. Now we can add genetic considerations to the com- 
parison, and incorporate into the calculation the three corrections just mentioned; 
the discrepancy is between 50 X 20 X 2 X 2 = 4,000-fold, and 80 X 20 X 2 X 2 = 
There is another approach to quantifying the discrepancy, based on the a-bomb- 
based estimate of the doubling dose, of -4 Sv equivalents of chronic ionizing radi- 
6,400-fold. 
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ation. Assuming this estimate applies to the gene or genes responsible for childhood 
leukemia, the Gardner data indicated a 6.4-fold increase in leukemia following an av- 
erage paternal dose of chronic ionizing radiation of about 0.2 Sv equivalent. Again 
assuming that the genetic component in childhood leukemia (i.e., the component that 
would respond to radiation) is approximately 576, then in the Gardner data, the dou- 
bling dose for “genetic”chi1dhood leukemia is 0.2 Sv equivalent/(6.4 X 20 X 2) = 
0.0008 Sv equivalent, a 5,000-fold discrepancy with the multifaceted estimate of the 
doubling dose derived from the a-bomb data. 
The barristers for the plaintiffs sought to explain this discrepancy with the pos- 
sibility that there were multiple genes in any one of which a mutation in a parent 
could be associated with leukemia in a child, plus the possibility that these genes 
were unusually sensitive to the genetic effects of radiation. It is true that in the Rus- 
sell 7-locus test, there is an approximately 18-fold difference between the most- and 
the least-radiation sensitive genes [Searle, 19741. Let us assume that mutation at any 
one of five different genetic loci can result in childhood leukemia, and the loci in- 
volved are 10 times more sensitive to the mutagenic effects of ionizing radiation than 
the average. Even if both these factors are applied to the Japanese data-an extraor- 
dinary concession-there would still be a 100-fold discrepancy between the results 
of the two studies. 
b. The non-specificity of the genetic affects of ionizing radiation. Finally, I note 
that the damage of ionizing radiation to DNA is generalized, “shotgun” in nature. 
As noted, the findings of the Gardner studies imply genetic sensitivities some 4,000- 
6,000 times greater than have been obtained in other studies on the genetic effects 
of radiation. There thus should have been a spectacular increase in the frequency 
of other genetic disease resulting from newly arisen mutations in the area covered 
by the Gardner studies. Although this expectation does not as yet appear to have 
been vigorously pursued, Jones and Wheater [ 19891 reported no increase in abnormal 
obstetrical outcomes in West Cumberland Hospital, which services the area covered 
by the Gardner studies. 
4. The results of other comparable epidemiological studies. Thus far the results of 
three attempts to duplicate the findings of the Gardner study have been published. The 
first of these attempts involved a case-control study of leukemia and non-Hodgkin’s 
lymphoma in the district surrounding the Dounreay nuclear installation in Scotland, 
where an apparent excess incidence of these two diseases had previously been re- 
ported [Committee on the Medical Aspects of Radiation in the Environment, 1988; 
Wakeford and Wilkie, 19891. The study revealed no excess risk in association with 
paternal employment at the Dounreay plant [Urquhart et al., 19911. However, the 
study was of such low statistical power that the results were compatible with the re- 
sults of either the a-bomb or the Gardner studies [Little, 1991bl. Subsequently, Kinlen 
et al. [1993a] conducted a study of leukemia and non-Hodgkin’s lymphoma in per- 
sons under 25 in the whole of Scotland, their survey thus including the area studied 
by Urquhart et al. [1991]. Again, no association with paternal employment at a nu- 
clear installation was observed, but now it was felt that the results were statistically 
inconsistent with the findings of Gardner et al. [1990a,b], [Kinlen, 19931. 
The second effort at confirmation of the Sellafield association was based on a 
case-control study of leukemia in children under the age of 15 living in the vicinity 
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of various nuclear facilities in the Province of Ontario, Canada [McLaughlin et al., 
19921. In this instance, no clusters of childhood leukemia had been established. This 
study found no association of childhood leukemia with fathers’ employment at a 
nuclear installation; the power of the study was such that the authors conclude the 
results are not consistent with those of the Gardner group. 
A third case-control study was conducted by Roman and associates [1993] on 
leukemia and non-Hodgkin’s lymphoma among children aged 0-4 years living in the 
West Berkshire and North Hampshire health districts of England. This area contains 
two nuclear installations and in it an excess of childhood leukemia had previously 
been documented [Roman et al., 19871. Five (9%) of the 54 cases and 14 (4%) of 
the 324 controls had fathers or mothers, or both, who had been employed by the nu- 
clear industry (relative risk 2.2; CI 0.6-6.9). Where the workers had been badged, 
the cumulative doses were very small, on the order of background, the largest 5 mSv 
equivalents. The investigators very prudently conclude that “if the association be- 
tween paternal preconceptual exposure to radiation and childhood leukemia we found 
is not a chance finding, the effect is unlikely to be due to paternal exposure to the 
forms of external penetrating ionizing radiation measured by monitoring devices.” 
In England, there does not seem to be a general increase in cancer near nuclear 
installations, with the possible exception of leukemia in young people [Forman et 
al., 19871. This fact, especially in light of the general failure to confirm the results of 
Gardner and associates, has prompted considerable interest in some non-radiogenic 
cause of leukemia clusters. For some years, Kinlen and associates [Kinlen, 1988; 
Kinlen et al., 1990; Kinlen and Hudson, 19911 have been exploring the hypothesis 
that leukemia clusters are associated with population mixing, i.e., with the coming 
together of individuals who have previously lived well apart from one another. It is 
suggested that these individuals introduce each other to formerly endemic viruses, 
and the resultant flurry of viral infections is followed by an excess of leukemia in 
children. Nuclear installations have usually been located in remote areas, so that the 
work force must be recruited from a wide area. Kinlen et al. [1993b] point out that 
the previously sparsely populated area in which the Dounreay nuclear installation 
is located is also an area of heavy population influx because of the in-migration of 
workers in the North Sea oil fields. In this connection, Kinlen [ 19931 also points out 
that the excess of leukemia in Seascale is not confined to children born there (the sub- 
jects of the Gardner study), but also occurs in children born elsewhere but who move 
to Seascale at a young age. The possibility that an unknown infectious agent might 
be implicated in the clusters of childhood leukemia in England and Scotland has 
been further advanced by the studies of Alexander and associates [Alexander, 1992; 
Alexander et al., 1990, 19921, who have observed that, in general, cases of leukemia 
live close to one another more often than controls and tend to be synchronous in time 
of onset. 
At the same time that interest has been growing in the possibility of an in- 
fectious etiology as the basis for leukemia clusters, a number of investigators 
[Boaag and Newell, 1991; Cuzick and Edwards, 1990; Openshaw et al., 1988; 
Stone, 1988; Whittemore et al., 19871 have been vigorously exploring the proper 
statistical approach to the role of chance in creating disease clusters. Indeed, the 
subject of clustering of health events has created so much interest (and controversy) 
that the American Journal of Epidemiology in 1990 published a most useful special 
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supplement reporting the results of a national conference sponsored by the Center for 
Disease Control [National Conference on Clustering of Health Events, 19901. Even 
if a disease is distributed at random with respect to population density, by chance 
there may be clusters which taken out of the context of the totality of the area sur- 
veyed, may appear to be significant. The proper test for the significance of a cluster 
within a defined geographic area after the fact (i.e., after its preliminary identifi- 
cation) is not to contrast frequency of disease within the cluster area with random 
expectation, but the question of how to correct for the role of chance in producing 
apparent clusters when the distribution of disease cases through a large, presumably 
heterogeneous area is unknown is proving difficult. At the very least, some equiva- 
lent to the adjustment made when multiple tests of significance are performed, such 
as a Bonferroni-type adjustment, seems indicated. 
5. A contrast of the findings in Seascale with those in surrounding communities. 
Even as the studies summarized in the preceding section were in progress, it was rec- 
ognized that the Gardner studies had involved only a fraction of the total population 
of Sellafield plant employees living in the vicinity of the Sellafield installation, and 
investigators began to cast a wider epidemiological net throughout Cumbria. Parker 
et al. [1993] established that in all of the Cumbria district (within which Seascale is 
located) there were, in the period 1950-1989, 10,363 children born to fathers who 
were employed at Sellafield at or before the date of conception of the child. The 
estimated total collective paternal preconceptual dose for this entire group was 539 
person Sv equivalents. Only 7% of this dose was associated with the fathers of chil- 
dren born in Seascale. There was no excess of leukemia in the remaining children. 
They conclude that their finding is “statistically incompatible with the proportion of 
risk that would have to be associated with Seascale births if these occupational radi- 
ation exposures were to be sufficient to explain the excess of childhood leukemia 
cases in Seascale.” Stated otherwise, the alleged leukemogenic effect of paternal 
exposure to ionizing radiation at Sellafield appeared to be unique to the Seascale 
district. 
Concurrently, Craft et al. [ 19931 analyzed the occurrence of cancer (including 
leukemia) in young people in the north of England by census wards for the period 
1968-1 985. This analysis identified several cancer “hot spots,” including Seascale. 
One of these additional hot spots, for acute lymphoblastic leukemia, was the ward of 
Egremont North, some 7 km north of the Sellafield installation. There were four chil- 
dren in this cluster; none of the fathers of these children were exposed to ionizing 
radiation at Sellafield prior to the conception of the children (even though employ- 
ment at Sellafield was common among the inhabitants of North Egremont) (Wake- 
ford, personal communication). 
As the various inconsistencies in their case discussed in these last two sections 
began to become apparent, counsel for the plaintiffs began to refer to a factor X at 
work in Seascale, which factor was not present elsewhere and somehow potentiated 
the expression of the leukemogenic mutations postulated to have resulted from the 
paternal exposures at Sellafield. Unfortunately for their case, this postulate still re- 
quires an induced mutation rate in response to these workplace exposures which is 
completely at odds with both the murine data and the Japanese experience. Equally 
unfortunate for their thesis are the clusters of leukemia in the vicinity of nuclear 
plants where there is no excess of paternal exposures in the nuclear workplace. 
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On October 8, 1993, after some 4 months of deliberation, the Hon. Mr. Justice 
French submitted a closely reasoned verdict which found for the defendant so con- 
vincingly that it is unlikely there will be an appeal. I quote briefly from his verdict: 
“In the result, the mechanisms proposed by the plaintiffs to account for the 
astonishingly larger mutation rate which the Gardner hypothesis requires, 
over and above any human experience or murine experiment, remain, I con- 
sider, in the present state of scientific knowledge, speculative. . . . The expla- 
nation based on a supra multiplicative effect between two factors (PPI’ and 
a “Seascale” factor in the form, e.g., of a virus or chemical) seems to me to 
be speculative also. Further, it poses two major problems. First, as I have 
said, it presupposes the high mutation rate which it sets out to explain; oth- 
erwise there would be nothing for the “Seascale factor” to synergize with. 
Secondly, it does not explain how the excess of leukemias can occur, e.g., 
in Egremont North involving children of fathers with no or, at most, trivial 
PPI. If some factors neither or none of which is PPI can cause leukemias in 
Egremont North, why is PPI necessary to explain the Seascale leukemias? 
Why should the Egremont North factors not have operated by themselves 
in Seascale with PPI, albeit present among Seascale fathers, present as an 
irrelevance? ... In my judgment, however, on the evidence before me the 
scales tilt decisively in favour of the defendants and the plaintiffs, there- 
fore, have failed to satisfy me on the balance of probabilities that PPI was 
a material contributory cause of the Seascale excess or, it must follow, 
of (a) the leukemia of Dorothy Reay or (b) the NHL2 of Vivien Hope.” 
[pp 73-74]. 
WHAT CAN BE DONE TO MINIMIZE FALSE POSITIVE OUTCOMES IN 
GENETIC EPIDEMIOLOGY 
I have probably given you much more detail concerning this fascinating im- 
broglio than any of you were hankering after this afternoon, but felt it important to 
get a full account of the matter into the genetic literature. While dilemmas such as 
this are what the judiciary is trained to meet, I suggest conventions can be devised 
which should lessen the possibility of such expensive and time-consuming extrava- 
ganzas in the future. Inasmuch as the continuing occurrence of highly visible false 
positive results will not contribute to the image of genetic epidemiology, it behooves 
us to take this matter seriously. 
In a sense, we find ourselves in the position of general epidemiologists in the 
1950s and 1960s, when the case-control approach to a variety of epidemiological 
studies began to be extensively employed. Unusual and non-reproducible findings 
became sufficiently prevalent that a group of investigators organized a Symposium 
on the Case-Control Method, held in Bermuda in April of 1978, the very useful 
proceedings of which were subsequently published [Ibrahim, 19781. Now, 15 years 
later, many of the issues discussed at that Conference are still with us. I need hardly 
PPI = paternal preconception irradiation. 
’NHL = non-Hodgkin’s lymphoma. 
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to remind you of the recent confusion concerning the linkage relationships of possible 
major genes associated with schizophrenia and the affective disorders. Furthermore, 
our sister field of teratogenesis is confronted with many of the same problems as 
those of genetic epidemiology [cf. Brent and Beckman, 19901, and there is reason to 
make common cause. 
Guided by that Conference, plus the sometimes conflicting results of recent ap- 
plications of genetic epidemiology, and especially the study I have reviewed in such 
detail, I am moved at this time to make four suggestions. The first two, unfortunately, 
if implemented are expensive, but in the end, to the extent that they reduce public 
and scientific confusion, and render multiple repeat studies unnecessary, are probably 
cost effective. 
The first suggestion is to pursue prospective-cohort studies wherever possible, 
studies in which the hypothesis or hypotheses to be tested are clearly defined. This 
is not the place for a detailed discussion of the relative merits of the case-control 
and prospective-cohort approaches. The latter generally permits a cleaner research 
design, but it must be admitted that there will be many situations where a clear state- 
ment of hypothesis is impossible, and one must engage in the fishing expedition to 
which the case-control study lends itself. Furthermore, funding agencies and those 
who fund them-and even investigators-cannot always summon the patience which 
a prospective study requires. 
The second positive suggestion is that whenever possible, epidemiological stud- 
ies designed to clarify a troublesome issue need to be pursued in duplicate, simulta- 
neously. Any finding not replicated in parallel studies is suspect. Such a tacit policy 
will require a degree of communication between investigators and a viewpoint on 
the part of funding agencies that do not exist at present. All over the world, most 
of the funding for large-scale epidemiological studies is now federal. Many appli- 
cations for study support will be stimulated by a government Request for Proposal, 
emanating, in the United States, e.g., from one of our National Institutes. Such re- 
quests could be committed to the support of at least two proposals, so planned that 
their results would be immediately and directly comparable. Some funding sources 
are already moving in this direction; it is an interesting question as to how direc- 
tive these sources should become to ensure cross-comparability between the studies 
they fund. Conversely, perhaps a Society such as ours can serve as an incubator for 
major studies planned from the beginning in duplicate on two independent and even 
cross-national populations. 
There will be situations where completely independent duplicate studies are im- 
practical. My own experience leads me to think of the complex follow-up studies on 
the delayed effects of the atomic bombs. Even here, the need for independent ap- 
praisals of the data set can be met. First, the research design must be scrutinized at 
the outset by a broad spectrum of research interests, in an effort to avoid the kinds of 
oversights that so often surface in retrospect. Second, the data, when available, can 
be made accessible to qualified, independent investigators, providing, of course, that 
the primary investigator has first access. 
The third suggestion is really only an affirmation of two established epidemi- 
ological principles. One is that because of the ever-present problem of establishing 
suitable controls, one attempts to establish a dose-rate effect within the “exposed” 
category. This implies that regression-type analyses (rather than 2 X 2 contrasts) be 
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employed whenever possible. The other is that conclusion regarding causality should 
be reinforced, where appropriate, by controlled studies involving an animal model. 
It seems certain that future epidemiological studies with a strong genetic compo- 
nent can only become more complex. Our ability to adjust to this growing complexity 
will be a test of the maturity and sophistication of genetic epidemiology. My fourth 
and final suggestion is that we all develop a very healthy skepticism toward even our 
own results, especially if the “result” is in obvious conflict with the results of previ- 
ous studies. With reference to the study which provided the text for this presentation, 
I would suggest there were already in the genetic literature at the time of the publica- 
tion of the Gardner study so many indications that the results constituted an extreme 
outlier, that much greater caution in their interpretation was called for than was ex- 
ercised. Perhaps, in this connection, the future programs of this Society can provide 
an arena in which this skepticism can be practiced. It would be especially helpful if 
this exercise were prepublication, while manuscripts and conclusions are still in the 
formative stages. 
In closing, I thank you for the privilege of serving as your president these past 
2 years. Some of you will recall the banner I unfurled at our first meeting: “Beyond 
the Human Genome Project: Genetic Epidemiology.” If we as a Society respond to 
this trend wisely, I would expect that within the next few years we should become a 
lively crossroads for much of the upcoming activity in genetic epidemiology. 
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